OBJECTIVE: The purpose of this paper is to describe pretest psychological functioning in a sample of colorectal cancer (CRC) patients undergoing genetic testing. We also explored the relationship among demographic, medical, family history and loss variables and current pretest distress, and those related to anticipated posttest distress. METHODS: This paper reports pretest findings from a prospective, longitudinal psychosocial survey. Data are presented on 220 CRC patients at pretest. RESULTS: We found a subgroup of CRC patients that are currently distressed and anticipate becoming depressed if they receive a positive genetic test result. There were significant associations among pretest distress, family history of CRC and loss related to CRC and anticipation of becoming depressed at posttest. CONCLUSIONS: The findings suggest that a subgroup of CRC patient's experience or anticipate distress that may warrant attention. Family history of CRC and losses related to CRC may be important indicators of posttest adjustment.
OBJECTIVE: The purpose of this paper is to describe pretest psychological functioning in a sample of colorectal cancer (CRC) patients undergoing genetic testing. We also explored the relationship among demographic, medical, family history and loss variables and current pretest distress, and those related to anticipated posttest distress. METHODS: This paper reports pretest findings from a prospective, longitudinal psychosocial survey. Data are presented on 220 CRCpatients at pretest. RESULTS: We found a subgroup of CRCpatients that are currently distressed and anticipate becoming depressed if they receive a positive genetic test result. There were significant associations among pretest distress, family history of CRC and loss related to CRC and anticipation of becoming depressed at posttest. CONCLUSIONS: The findings suggest that a subgroup of CRCpatient's experience or anticipate distress that may warrant attention. Family history of CRC and losses related to CRC may be important indicators of posttest adjustment.
Authors: Eveline M A Bleiker; Mary Jane Esplen; Bettina Meiser; Helle Vendel Petersen; Andrea Farkas Patenaude Journal: Fam Cancer Date: 2013-06 Impact factor: 2.375
Authors: Allison Werner-Lin; Jennifer L Young; Catherine Wilsnack; Shana L Merrill; Victoria Groner; Mark H Greene; Payal P Khincha Journal: Fam Cancer Date: 2020-07 Impact factor: 2.375
Authors: Kathy E Watkins; Christine Y Way; Deborah M Gregory; Holly M LeDrew; Valerie C Ludlow; Mary Jane Esplen; Jeffrey J Dowden; Janet E Cox; G William N Fitzgerald; Patrick S Parfrey Journal: BMC Psychol Date: 2013-04-30
Authors: Karin M Landsbergen; Judith B Prins; Han G Brunner; Floris W Kraaimaat; Nicoline Hoogerbrugge Journal: Fam Cancer Date: 2009-03-28 Impact factor: 2.375
Authors: Mary Jane Esplen; Mario Cappelli; Jiahui Wong; Joan L Bottorff; Jon Hunter; June Carroll; Michel Dorval; Brenda Wilson; Judith Allanson; Kara Semotiuk; Melyssa Aronson; Louise Bordeleau; Nicole Charlemagne; Wendy Meschino Journal: BMJ Open Date: 2013-03-13 Impact factor: 2.692